Toscafund's Spire Healthcare Bid on Par With Ramsay's Failed Attempt -- Market Talk

Dow Jones05-14

0741 GMT - Spire Healthcare shareholder Toscafund is betting a takeover bid for the price at which Australia's Ramsay Health Care failed to win over enough investors in the U.K. healthcare provider will work five years later. "While Ebitda is now 50% higher, the investment story has been somewhat volatile, impacted by [National Health Service] demand uncertainty and government-driven cost increases," RBC analysts say in a research note. Toscafund proposed a cash bid of 250 pence a share, the price of Ramsay's offer in 2021. Back then, the deal fell short of the required majority when Spire shareholders voted. Lack of NHS commissioning drove Spire shares from a one-year peak of about 250 pence in September to 150.40 pence as of Wednesday's close, according to RBC. Spire shares jump 41% to 212 pence. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

May 14, 2026 03:41 ET (07:41 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635791320?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 15:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635791320","market":"us","top_or_hot":-1,"title":"Toscafund's Spire Healthcare Bid on Par With Ramsay's Failed Attempt -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0741 GMT - Spire Healthcare shareholder Toscafund is betting a takeover bid for the price at which Australia's <a href=\"https://laohu8.com/S/RMSYF\">Ramsay Health Care</a> failed to win over enough investors in the U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. healthcare provider will work five years later. \"While Ebitda is now 50% higher, the investment story has been somewhat volatile, impacted by [National Health Service] demand uncertainty and government-driven cost increases,\" RBC analysts say in a research note. Toscafund proposed a cash bid of 250 pence a share, the price of Ramsay's offer in 2021. Back then, the deal fell short of the required majority when Spire shareholders voted. Lack of NHS commissioning drove Spire shares from a one-year peak of about 250 pence in September to 150.40 pence as of Wednesday's close, according to RBC. Spire shares jump 41% to 212 pence. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 14, 2026 03:41 ET (07:41 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toscafund's Spire Healthcare Bid on Par With Ramsay's Failed Attempt -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToscafund's Spire Healthcare Bid on Par With Ramsay's Failed Attempt -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-14 15:41</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0741 GMT - Spire Healthcare shareholder Toscafund is betting a takeover bid for the price at which Australia's <a href=\"https://laohu8.com/S/RMSYF\">Ramsay Health Care</a> failed to win over enough investors in the U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. healthcare provider will work five years later. \"While Ebitda is now 50% higher, the investment story has been somewhat volatile, impacted by [National Health Service] demand uncertainty and government-driven cost increases,\" RBC analysts say in a research note. Toscafund proposed a cash bid of 250 pence a share, the price of Ramsay's offer in 2021. Back then, the deal fell short of the required majority when Spire shareholders voted. Lack of NHS commissioning drove Spire shares from a one-year peak of about 250 pence in September to 150.40 pence as of Wednesday's close, according to RBC. Spire shares jump 41% to 212 pence. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 14, 2026 03:41 ET (07:41 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0128526141.USD","symbol_name":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2635791320","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2635791320","pubTimestamp":1778744460,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0741 GMT - Spire Healthcare shareholder Toscafund is betting a takeover bid for the price at which Australia's Ramsay Health Care failed to win over enough investors in the U.K. healthcare provider will work five years later. \"While Ebitda is now 50% higher, the investment story has been somewhat volatile, impacted by [National Health Service] demand uncertainty and government-driven cost increases,\" RBC analysts say in a research note. Toscafund proposed a cash bid of 250 pence a share, the price of Ramsay's offer in 2021. Back then, the deal fell short of the required majority when Spire shareholders voted. Lack of NHS commissioning drove Spire shares from a one-year peak of about 250 pence in September to 150.40 pence as of Wednesday's close, according to RBC. Spire shares jump 41% to 212 pence. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","XBI":"SPDR S&P Biotech ETF","RHC.AU":"RAMSAY HEALTH CARE LTD","SR":"SPIRE","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4581":"高盛持仓","BK7113":"保健护理机构","XLV":"健康照护类股ETF-SPDR","HCSG":"Healthcare Svcs Group Inc","BK4588":"碎股","BK4137":"综合支持服务","BK4197":"燃气公用事业","LABU":"三倍做多标普生物-Direxion","BK4585":"ETF&股票定投概念"},"translate_title":"Toscafund的Spire Healthcare出价与Ramsay的失败尝试相当——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":0.6,"RHC.AU":0.9,"HCSG":1.5,"SR":1.5,"XBI":0.6,"XLV":1.5},"content_text":"0741 GMT - Spire Healthcare shareholder Toscafund is betting a takeover bid for the price at which Australia's Ramsay Health Care failed to win over enough investors in the U.K. healthcare provider will work five years later. \"While Ebitda is now 50% higher, the investment story has been somewhat volatile, impacted by [National Health Service] demand uncertainty and government-driven cost increases,\" RBC analysts say in a research note. Toscafund proposed a cash bid of 250 pence a share, the price of Ramsay's offer in 2021. Back then, the deal fell short of the required majority when Spire shareholders voted. Lack of NHS commissioning drove Spire shares from a one-year peak of about 250 pence in September to 150.40 pence as of Wednesday's close, according to RBC. Spire shares jump 41% to 212 pence. (adria.calatayud@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2026 03:41 ET (07:41 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635791320","isCrawlerRequest":true}